KRN4884 is a K⁺ channel opener that activates cardiac KATP channels by reducing channel sensitivity to ATP and directly stimulating channel opening; it significantly lowers serum triglyceride levels in rats after oral administration, comparable to the effect of Clofibrate, by reducing triglyceride content in both chylomicrons and very low-density lipoprotein (VLDL), and increases lipoprotein lipase (LPL) activity in adipose tissue and skeletal muscle.